Myung J. Goh

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

Risk-stratified MRI surveillance for hepatocellular carcinoma in cirrhosis: a prospective cohort study.

Risk-stratified MRI surveillance for hepatocellular carcinoma in cirrhosis: a prospective cohort study.

Journal: European radiology

Published: April 03, 2026

Tailored proton beam therapy for hepatocellular carcinoma: Addressing unmet needs through a multidisciplinary approach.

Tailored proton beam therapy for hepatocellular carcinoma: Addressing unmet needs through a multidisciplinary approach.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 12, 2026

Metabolic Dysfunction-Associated Fibrosis 5 Score and the Risk of Liver-Related Events in the General Population.

Metabolic Dysfunction-Associated Fibrosis 5 Score and the Risk of Liver-Related Events in the General Population.

Journal: Gut and liver

Published: December 23, 2025

Optimal screening criteria for metabolic dysfunction-associated steatotic liver disease with fibrosis.

Optimal screening criteria for metabolic dysfunction-associated steatotic liver disease with fibrosis.

Journal: Annals of hepatology

Published: November 15, 2025

Prognostic factors in first-line atezolizumab-bevacizumab treatment of intermediate or advanced hepatocellular carcinoma.

Prognostic factors in first-line atezolizumab-bevacizumab treatment of intermediate or advanced hepatocellular carcinoma.

Journal: PloS one

Published: October 16, 2025

Safety and Efficacy of Combining Metastasis-Directed Stereotactic Ablative Radiation Therapy with Tyrosine Kinase Inhibitors Versus Immune Checkpoint Inhibitors in Metastatic Hepatocellular Carcinoma.

Safety and Efficacy of Combining Metastasis-Directed Stereotactic Ablative Radiation Therapy with Tyrosine Kinase Inhibitors Versus Immune Checkpoint Inhibitors in Metastatic Hepatocellular Carcinoma.

Journal: Cancer research and treatment

Published: September 05, 2025

Predicting early progression to atezolizumab-bevacizumab in hepatocellular carcinoma: a clinical and imaging-based scoring system.

Predicting early progression to atezolizumab-bevacizumab in hepatocellular carcinoma: a clinical and imaging-based scoring system.

Journal: European radiology

Published: May 26, 2025

Risk-based selection of treatment strategies in hepatocellular carcinoma with macrovascular invasion.

Risk-based selection of treatment strategies in hepatocellular carcinoma with macrovascular invasion.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: May 12, 2025

Evaluation of Exosome-derived Small RNAs as Potential Biomarkers for Pancreatic Ductal Adenocarcinoma Using Next-generation Sequencing.

Evaluation of Exosome-derived Small RNAs as Potential Biomarkers for Pancreatic Ductal Adenocarcinoma Using Next-generation Sequencing.

Journal: Annals of laboratory medicine

Published: March 11, 2025

Primary Cholangiocarcinoma of the Liver Presenting as a Complicated Hepatic Cyst: A Diagnostic Challenge.

Primary Cholangiocarcinoma of the Liver Presenting as a Complicated Hepatic Cyst: A Diagnostic Challenge.

Journal: The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi

Published: October 29, 2024

A Risk Prediction Model for Hepatocellular Carcinoma in the General Population Without Traditional Risk Factors for Liver Disease.

A Risk Prediction Model for Hepatocellular Carcinoma in the General Population Without Traditional Risk Factors for Liver Disease.

Journal: Journal of gastroenterology and hepatology

Published: October 15, 2024

Miliary Tuberculosis Initially Presenting as an Isolated Hepatic Abscess.

Miliary Tuberculosis Initially Presenting as an Isolated Hepatic Abscess.

Journal: The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi

Published: October 11, 2024

Showing 1-12 of 54

Last Updated: 09/26/2026